XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 6,036 $ 19,709
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 4,235 4,046
Amortization of deferred debt issuance costs 1,443 1,407
Amortization 14,018 13,992
Stock-based compensation 13,863 6,240
Deferred income taxes (2,659) 1,865
Non-cash adjustments to fair value of contingent consideration liability 3,962 (6,545)
Increase (decrease) in cash flows from changes in assets and liabilities:    
Accounts receivable 18,984 (908)
Inventories (7,475) (5,049)
Accounts payable (7,317) 12,999
Accrued compensation and benefits (8,181) (19,829)
Other assets (5,422) (6,781)
Other liabilities 10,047 7,975
Net cash provided by operating activities 41,534 29,121
Cash flows from investing activities:    
Purchases of property, plant and equipment (3,779) (2,035)
Other 850 0
Net cash used in investing activities (2,929) (2,035)
Cash flows from financing activities:    
Payments on term loan (14,588) 0
Payments on revolving line of credit (166,000) (168,000)
Proceeds from revolving line of credit 166,000 254,000
Payments to redeem convertible notes 0 (70,000)
Payments related to contingent consideration (7,166) (26,928)
Dividends paid on common stock (6,180) (6,153)
Other, net (464) 67
Net cash used in financing activities (28,398) (17,014)
Effect of exchange rate changes on cash and cash equivalents 819 (513)
Net increase in cash and cash equivalents 11,026 9,559
Cash and cash equivalents at beginning of period 24,459 24,296
Cash and cash equivalents at end of period 35,485 33,855
Non-cash financing activities:    
Dividends payable $ 6,186 $ 6,158